Presentations

Below is a list of conferences and seminars at which my work has been (or will be) presented. You can download abstracts, slides, posters, and papers where applicable. If you’re looking for something but can’t find it, please let me know.

For other outputs visit the ‘Publications’ page.

2020

Paradigm shifts in health state valuation – what is the future of utilities for QALYs? (issue panel) // 20th May // ISPOR Virtual Conference [slides]

Development and qualitative testing of EQ-5D-5L bolt-ons for cognition and vision (poster)// 1st March // EuroQol Early Career Researcher meeting, Prague, Czech Republic [poster]

Risk calculation engines, cost-effectiveness analysis, and Microsoft Excel: lessons from an intractable model (paper) // 8th January // Health Economists’ Study Group, Newcastle University, Newcastle, UK

The impact of a digital sleep-improvement program on health care costs (poster) // 7th January // Health Economists’ Study Group, Newcastle University, Newcastle, UK [abstract]

2019

Development of EQ-5D-5L bolt-ons for cognition and vision (poster) // 5th November // ISPOR Europe, Copenhagen, Denmark [abstract] [poster]

The impact of a digital sleep-improvement program on health care costs // 5th November // ISPOR Europe, Copenhagen, Denmark [abstract]

Drop dead: is anchoring at ‘dead’ a theoretical requirement in health state valuation? // 8th January // Health Economists’ Study Group, University of York, York, UK 

2018

Drop dead: is anchoring at ‘dead’ a theoretical requirement in health state valuation? // 21st September // 35th EuroQol Group Scientific Plenary, Lisbon, Portugal

Optimising risk-based screening: the case of diabetic eye disease // 3rd June // Health Technology Assessment International, Vancouver, Canada [abstract]

Long-term evaluation of broad mental health interventions: a review // 3rd June // Health Technology Assessment International, Vancouver, Canada [abstract]

Building bridges not walls: can we develop sustainable and sharable cost-effectiveness models? // 4th June // Health Technology Assessment International, Vancouver, Canada [slides]

Individualised cost-effectiveness analysis in risk-based screening // 20th February // AUHE Seminar Series, University of Leeds, Leeds, UK

2017

Putting the ‘extra’ in animal welfare: health maximisation for non-human animals // 27th March // International Society for Economics and Social Sciences of Animal Health Inaugural Meeting, Aviemore, UK [poster]

The true cost of missing dogs – a case study using Harvey’s Law // 27th March // International Society for Economics and Social Sciences of Animal Health Inaugural Meeting, Aviemore, UK

Systematic review and meta-analysis of health state utility values for diabetic retinopathy: implications for model-based economic evaluation // 4th January // Health Economists’ Study Group, University of Birmingham, Birmingham, UK

2016

Risk-based screening for diabetic retinopathy: a model for individualisation // 8th September // Third EuHEA PhD Student-Supervisor and Early Career Researcher Conference, Universitat Internacional de Catalunya, Barcelona, Spain

Microcosting diabetic eye screening: estimation of personal expense, attendance and health care resource use // 24th June // European Association for the Study of Diabetes Eye Complications Study Group: 26th Annual Meeting, Manchester, UK

Health-related quality of life of people attending screening for diabetic retinopathy within a trial setting // 24th June // European Association for the Study of Diabetes Eye Complications Study Group: 26th Annual Meeting, Manchester, UK [poster]

10 year observational study of patient related outcomes during expansion to full population coverage of a systematic diabetes eye care programme – the Liverpool Diabetic Eye Study // 24th June // European Association for the Study of Diabetes Eye Complications Study Group: 26th Annual Meeting, Manchester, UK

10 year observational study of patient related outcomes during expansion to full population coverage of a systematic diabetes eye care programme – the Liverpool Diabetic Eye Study // 1st May // ARVO 2016, Seattle, Washington, USA

Risk-based screening for diabetic retinopathy: A model for individualisation // 21st April // HEDS Seminar Series, University of Sheffield, Sheffield, UK

Cost-effectiveness of a risk-based screening programme for diabetic retinopathy // 23rd February // HERAN Seminar, University of Nottingham, Nottingham, UK

Individualised cost-effectiveness analysis in risk-based screening: practical and ethical? // 6th January // Health Economists’ Study Group, University of Manchester, Manchester, UK [paper]

Discussion of ‘Identification and treatment of gestational diabetes: an economic evaluation’ // 6th January // Health Economists’ Study Group, University of Manchester, Manchester, UK [slides]

2015

Cost-effectiveness of a risk-based screening programme for diabetic retinopathy: a modelling approach // 28th June // EASDec 2015: 25th Annual Meeting, University of Turin, Turin, Italy [citation]

Cost-effectiveness of a specialist depression service for resistant depression // 29th March // 12th Workshop on Costs and Assessment in Psychiatry, International Center of Mental Health Policy and Economics, Venice, Italy [citation]

Individualised cost-effectiveness analysis in risk-based screening: practical and ethical? // 2nd March // Personalised Medicine and Resource Allocation conference, University of Oxford, Oxford, UK [abstract] [slides] [video]

2014

Anchors aweigh: are current reference states for health valuation fit for purpose? // 9th September // HER@N seminar, University of Nottingham, Nottingham, UK

2013

Stroke specific vocational rehabilitation (SSVR): a feasibility randomised controlled trial // 4th December // 8th UK Stroke Forum Conference, Harrogate International Centre, Harrogate, UK [poster] [citation]

Subjective well-being and generic preference-based measures of health: an empirical contribution // 10th January // Health Economists’ Study Group, University of Exeter, Exeter, UK [paper]

Discussion of ‘Cost-equality analysis of health care programmes – a methodological case study of the UK Bowel Cancer Screening Programme’ // 10th January // Health Economists’ Study Group, University of Exeter, Exeter, UK [slides]

2012

Pre-discharge occupational therapy home visits for patients with a stroke: results of a feasibility randomised controlled trial (RCT) // 5th December // 7th UK Stroke Forum Conference, Harrogate International Centre, Harrogate, UK [slides] [citation]

Economic evaluation of occupational therapy pre-discharge home visits for patients with a stroke: issues arising // 10th October // The role of health economics in responding to the research needs of the health service through CLAHRCs, University of Birmingham, Birmingham, UK [slides]

Discussion of ‘Operationalising the capabilities approach for outcome measurement in mental health studies’ // 26th June // Health Economists’ Study Group, University of Oxford, Oxford, UK [slides]

Readiness for treatment in personality disorder // 20th June // Health Services Research Network Symposium, Manchester, UK [slides]

Cost implications of treatment non-completion in personality disorder // 9th March // East Midlands & South Yorkshire MHRN Annual Research Meeting, Nottingham, UK [slides] [video]

Findings from the CLAHRC-NDL project: ‘The costs of non-completion in treatment for personality disorder’ // 27th January // Engaging People with Personality Difficulties in Services, University of Nottingham, Nottingham, UK

Optimising cost-effectiveness in risk-based screening programmes: a modelling approach // 12th January // Health Economists’ Study Group and Collège des Économistes de la Santé Workshop, Maison Méditerranéenne des Sciences de l’Homme, Aix en Provence, France

2011

A comparison of subjective well-being and generic preference-based measures of health // 14th June // HER@N seminar, University of Nottingham, Nottingham, UK [slides]

Findings from the CLAHRC-NDL project: ‘The costs of non-completion in treatment for personality disorder’ // 20th May // Personality Difficulties Development Event, Lincolnshire Partnership NHS Foundation Trust, Sleaford, UK

The cost implications of non-completion: a Markov model // 24th March // British and Irish Group for the Study of Personality Disorder, University of Oxford, Oxford, UK // [slides]